Hereditary hemochromatosis

Journal of the College of Physicians and Surgeons Pakistan

Volumn 25, Issue 9, 2015, Pages 644-647

  Parkash, Om ^a   Akram, Muhammad ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Child score; Cirrhosis; Hemochromatosis; Pakistan

Indexed keywords

FERRITIN; IRON; TRANSFERRIN; ALANINE AMINOTRANSFERASE; MEMBRANE PROTEIN;

ADULT; ARTHRALGIA; ARTICLE; ASCITES; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; HEART DISEASE; HEMOCHROMATOSIS; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMPOTENCE; IRON BLOOD LEVEL; LABORATORY TEST; LIBIDO DISORDER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION TEST; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OBSERVATIONAL STUDY; PIGMENT DISORDER; TERTIARY CARE CENTER; TRANSFERRIN BLOOD LEVEL; UNIVERSITY HOSPITAL; WEAKNESS; AGED; BLOOD; COMPLICATION; GENETICS; LIVER; METABOLISM; PAKISTAN; PHENOTYPE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; FERRITINS; HEMOCHROMATOSIS; HUMANS; IRON; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PAKISTAN; PHENOTYPE; TRANSFERRIN;

EID: 84941107889     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
2. McAvoy NC, Hayes PC. The cirrhosis epidemic in the UK: evaluating the causes in a European context. Expert Rev Gastroenterol Hepatol 2007; 1:41-5.
3. Song GJ, Feng B, Rao HY, Wei L. Etiological features of cirrhosis inpatients in Beijing, China. Chin Med J (Engl) 2014; 126:2430-4.
4. Ahmad K. Pakistan: a cirrhotic state? Lancet 2004; 364:1843-4.
5. Khan P, Ahmad A, Muhammad N, Khan TM, Ahmad B. Screening of 110 cirrhotic patients for hepatitis B and C at Saidu Teaching Hospital, Saidu Sharif, Swat. J Ayub Med Coll Abbottabad 21:119-21.
6. Bukhtiari N, Hussain T, Iqbal M, Malik AM, Qureshi AH, Hussain A. Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc 2003; 53:136-40.
7. Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med 2004; 350:2383-97.
8. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139:393-408, e1-2.
9. Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis. J Intern Med 2012; 271:51-63.
10. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary haemochromatosis. N Engl J Med 1985; 313:1256-62.
11. Elmberg M, Hultcrantz R, Simard JF, Stal P, Pehrsson K, Askling J. Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study. J Intern Med 2012; 272:45-54.
12. Adams PC, Barton JC. Haemochromatosis. Lancet 2012; 370:1855-60.
13. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Haemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005; 352:1769-78.
14. Siddique A, Kowdley KV. Review article: the iron overload syndromes. Aliment Pharmacol Ther 2012; 35:876-93.
15. van Bokhoven MA, van Deursen CT, Swinkels DW. Diagnosis and management of hereditary haemochromatosis. BMJ 2011; 342:c7251.
16. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, et al. Iron-overload-related disease in HFE hereditary haemochromatosis. N Engl J Med 2008; 358:221-30.
17. Falize L, Guillygomarc'h A, Perrin M, Laine F, Guyader D, Brissot P, et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006; 44:472-7.
18. Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 2001; 80:737-44.
19. Moyer TP, Highsmith WE, Smyrk TC, Gross JB, Jr. Hereditary hemochromatosis: laboratory evaluation. Clin Chim Acta 2005; 412:1485-92.
20. Gleeson F, Ryan E, Barrett S, Crowe J. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Eur J Gastroenterol Hepatol 2004; 16:859-63.
21. Bacon BR, Sadiq SA. Hereditary hemochromatosis: presentation and diagnosis in the 1990s. Am J Gastroenterol 1997; 92:784-9.
22. Zamani F, Bagheri Z, Bayat M, Fereshtehnejad SM, Basi A, Najmabadi H, et al. Iranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutations. Med Sci Monit 2000; 18:CR622-9.
23. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guidelines by the American Association for the study of liver diseases. Hepatology 2011; 54:328-43.
24. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116:193-207.
25. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.